Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation

Cell Cycle

Volumn 10, Issue 16, 2011, Pages 2751-2762

  Ferrer, Irene ^a,d   Blanco Aparicio, Carmen ^a   Peregrina, Sandra ^a   Cañamero, Marta ^b   Fominaya, Jesús ^a   Cecilia, Yolanda ^b   Lleonart, Matilde ^c   Hernandez Losa, Javier ^c   Ramon Y Cajal, Santiago ^c   Carnero, Amancio ^a,d  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b Centro Nacional de Investigations Oncológicas   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d CSIC   (Spain)

Author keywords

Cancer; Cell cycle; P53; PPP1R9B; Retinoblastoma; Spinophilin; Tumor suppressor

Indexed keywords

ARF PROTEIN; DOXORUBICIN; ETOPOSIDE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1A; PHOSPHOPROTEIN PHOSPHATASE 1CA; PROTEIN P53; RETINOBLASTOMA PROTEIN; SPINOPHILIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN CELL; MEDIATOR; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

EID: 80051752831     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.16.16422     Document Type: Article

References (68)

1. Querzoli P., Albonico G., di Iasio M.G., Ferretti S., Rinaldi R., Cariello A., et al. Biophenotypes and survival of BRCA1 and Tp53 deleted breast cancer in young women. Breast Cancer Res Treat 2001; 66:135-142; DOI: 10.1023/A:1010643515095; PMID: 11437099.
2. Caduff R.F., Svoboda-Newman S.M., Ferguson A.W., Frank TS. Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast. Virchows Arch 1999; 434:517-22; DOI: 10.1007/ s004280050377; PMID: 10394886.
3. Maitra A., Tavassoli F.A., Albores-Saavedra J., Behrens C., Wistuba I.I., Bryant D., et al. Molecular abnormalities associated with secretory carcinomas of the breast. Hum Pathol 1999; 30:1435-40; DOI: 10.1016/S0046- 8177(99)90165-X; PMID: 10667421.
4. Abujiang P., Mori T.J., Takahashi T., Tanaka F., Kasyu I., Hitomi S., et al. Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 1998; 17:3029-3033; DOI: 10.1038/sj.onc.1202230; PMID: 9881705.
5. Porter D.E., Steel C.M., Cohen B.B., Wallace M.R., Carothers A., Chetty U., et al. Genetic linkage analysis applied to unaffected women from families with breast cancer can discriminate high- from low-risk individuals. Br J Surg 1993; 80:1381-5; DOI: 10.1002/ bjs.1800801108; PMID: 8252342.
6. Porter D.E., Cohen B.B., Wallace M.R., Carothers A., Steel C.M. Linkage mapping in familial breast cancer: improved localisation of a susceptibility locus on chromosome 17q12-21. Int J Cancer 1993; 53:188-198; DOI: 10.1002/ijc.2910530203; PMID: 8425756.
7. Porter D.E., Cohen B.B., Wallace M.R., Smyth E., Chetty U., Dixon J.M., et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994; 81:1512-5; DOI: 10.1002/ bjs.1800811038; PMID: 7820489.
8. Cohen B.B., Porter D.E., Wallace M.R., Carothers A., Steel C.M. Linkage of a major breast cancer gene to chromosome 17q12-21: results from 15 Edinburgh families. Am J Hum Genet 1993; 52:723-729; PMID: 8460638.
9. Smith S.A., Easton D.F., Ford D., Peto J., Anderson K., Averill D., et al. Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21. Am J Hum Genet 1993; 52:767-776; PMID: 8460642.
10. Easton D.F., Bishop D.T., Ford D., Crockford G.P. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993; 52:678-701; PMID: 8460634.
11. Tseng S.L., Yu I.C., Yue C.T., Chang S.F., Chang T.M., Wu C.W., et al. Allelic loss at BRCA1, BRCA2 and adjacent loci in relation to Tp53 abnormality in breast cancer. Genes Chromosomes Cancer 1997; 20:377-82; DOI: 10.1002/(SICI)1098-2264(199712)20:4<377::AIDGCC9> 3.0.CO;2-Z; PMID: 9408754.
12. Allen P.B., Ouimet C.C., Greengard P. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci USA 1997; 94:9956-9961; DOI: 10.1073/pnas.94.18.9956; PMID: 9275233.
13. Satoh A., Nakanishi H., Obaishi H., Wada M., Takahashi K., Satoh K., et al. Neurabin-II/spinophilin. An actin filament- binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites. J Biol Chem 1998; 273:3470-3475; DOI: 10.1074/jbc.273.6.3470; PMID: 9452470.
14. Sarrouilhe D., di Tommaso A., Metaye T., Ladeveze V Spinophilin: from partners to functions Biochimie 2006; 88:1099-113; DOI: 10.1016/j.biochi. 2006.04.010; PMID: 16737766.
15. Vivo M., Calogero R.A., Sansone F., Calabro V., Parisi T., Borrelli L., et al. The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein. J Biol Chem 2001; 276:14161-14169; PMID: 11278317.
16. Hsieh-Wilson L.C., Allen P.B., Watanabe T., Nairn A.C., Greengard P. Characterization of the neuronal targeting protein spinophilin and its interactions with protein phosphatase-1. Biochemistry 1999; 38:4365-4373; DOI: 10.1021/bi982900m; PMID: 10194355.
17. Ouimet C.C., Katona I., Allen P., Freund T.F., Greengard P. Cellular and subcellular distribution of spinophilin, a PP1 regulatory protein that bundles F-actin in dendritic spines. J Comp Neurol 2004; 479:374-388; DOI: 10.1002/cne.20313; PMID: 15514983.
18. Feng J., Yan Z., Ferreira A., Tomizawa K., Liauw J.A., Zhuo M., et al. Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci USA 2000; 97:9287-9292; DOI: 10.1073/pnas.97.16.9287; PMID: 10922077.
19. Tsukada M., Prokscha A., Eichele G. Neurabin II mediates doublecortin-dephosphorylation on actin filaments. Biochem Biophys Res Commun 2006; 343:839-847; DOI: 10.1016/j.bbrc.2006.03.045; PMID: 16564023.
20. Bielas S.L., Serneo F.F., Chechlacz M., Deerinck T.J., Perkins G.A., Allen P.B., et al. Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist. Cell 2007; 129:579-591; DOI: 10.1016/j.cell.2007.03.023; PMID: 17482550.
21. Berndt N. Protein dephosphorylation and the intracellular control of the cell number. Front Biosci 1999; 4:22-42; DOI: 10.2741/Berndt; PMID: 9872729.
22. Liu C.W., Wang R.H., Dohadwala M., Schonthal A.H., Villa-Moruzzi E., Berndt N. Inhibitory phosphorylation of PP1alpha catalytic subunit during the G(1)/S transition. J Biol Chem 1999; 274:29470-29475; DOI: 10.1074/jbc.274.41. 29470; PMID: 10506210.
23. Castro M.E., Ferrer I., Cascon A., Guijarro M.V., Lleonart M., Cajal S.R., et al. PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis 2008; 29:491-9; DOI: 10.1093/carcin/ bgm246; PMID: 18204081.
24. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9:153-166; DOI: 10.1038/nrc2602; PMID: 19238148.
25. Sherr C.J. Principles of tumor suppression. Cell 2004; 116:235-246; DOI: 10.1016/S0092-8674(03)01075-4; PMID: 14744434.
26. Noonan E.J., Place R.F., Basak S., Pookot D., Li L.C. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010; 1:349-358; PMID: 20948989.
27. Ayllón V., Martinez A.C., Garcia A., Cayla X., Rebollo A. Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivationinduced apoptosis. EMBO J 2000; 19:2237-2246; DOI: 10.1093/emboj/19.10.2237; PMID: 10811615.
28. 2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J Neurochem 1997; 68:2119-28; DOI: 10.1046/j.1471- 4159.1997.68052119.x; PMID:9109540.
29. Sherr C.J., McCormick F The RB and p53 pathways in cancer Cancer Cell 2002; 2:103-12; DOI: 10.1016/ S1535-6108(02)00102-2; PMID: 12204530.
30. ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2000; 2:148-155; PMID: 10707085.
31. Chao S.K., Horwitz S.B., McDaid HM Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence. Oncotarget 2011; 2:89-98; PMID: 21399233.
32. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366:704-707; DOI: 10.1038/366704a0; PMID: 8259215.
33. INK4a. Cell 1997; 88:593-602; DOI: 10.1016/ S0092-8674(00)81902-9; PMID: 9054499.
34. ARF. Proc Natl Acad Sci USA 1997; 94:669-673; DOI: 10.1073/pnas.94.2.669; PMID: 9012842.
35. ARF. Cell 1997; 91:649-59; DOI: 10.1016/ S0092-8674(00)80452-3; PMID: 9393858.
36. Ferrer I., Cañamero M., Cecilia Y., Blanco-Aparicio C., Carnero A. Spinophilin loss contributes to tumorigenesis in vivo. Cell Cycle 2011; In press; PMID: 21670604.
37. ARF links the tumour suppressors RB and p53. Nature 1998; 395:124-125; DOI: 10.1038/25867; PMID: 9744267.
38. ARF links the tumour suppressor p53 to Ras. Nature 1998; 395:125-126; DOI: 10.1038/25870; PMID: 9744268.
39. Laurie N.A., Donovan S.L., Shih C.S., Zhang J., Mills N., Fuller C., et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444:61-6; DOI: 10.1038/ nature05194; PMID: 17080083.
40. ARF induces p53-dependent cell cycle arrest but not apoptosis. Cell Cycle 2005; 4:465-472; DOI: 10.4161/cc.4.3.1526; PMID: 15701968.
41. Efeyan A., Garcia-Cao I., Herranz D., Velasco-Miguel S., Serrano M. Tumour biology: Policing of oncogene activity by p53. Nature 2006; 443:159; DOI: 10.1038/443159a; PMID: 16971940.
42. Molina-Pinelo S., Ferrer I., Blanco-Aparicio C., Peregrino S., Pastor M.D., Vega J.A., et al. Downregulation of spinophilin in lung tumors contributes to tumorigenesis. J Pathol 2011; In press; PMID:21598252.
43. Shmueli A., Gdalyahu A., Sapoznik S., Sapir T., Tsukada M., Reiner O Site-specific dephosphorylation of doublecortin (DCX) by protein phosphatase 1 (PP1). Mol Cell Neurosci 2006; 32:15-26; DOI: 10.1016/j. mcn.2006.01.014; PMID: 16530423.
44. Santra M., Liu X.S., Santra S., Zhang J., Zhang R.L., Zhang Z.G., et al. Ectopic expression of doublecortin protects adult rat progenitor cells and human glioma cells from severe oxygen and glucose deprivation. Neuroscience 2006; 142:739-52; DOI: 10.1016/j. neuroscience.2006.06.065; PMID:16962712.
45. Santra M., Zhang X., Santra S., Jiang F., Chopp M Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells Cancer Res 2006; 66:11726-35; DOI: 10.1158/0008-5472.CAN- 06-1978; PMID:17178868.
46. Santra M., Santra S., Roberts C., Zhang R.L., Chopp M Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion J Neurochem 2009; 108:231-45; DOI: 10.1111/j.1471- 4159.2008.05758.x; PMID:19094064.
47. Terry-Lorenzo R.T., Carmody L.C., Voltz J.W., Connor J.H., Li S., Smith F.D., et al. The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits. J Biol Chem 2002; 277:27716-24; DOI: 10.1074/jbc. M203365200; PMID: 12016225.
48. MacMillan L.B., Bass M.A., Cheng N., Howard E.F., Tamura M., Strack S., et al. Brain actin-associated protein phosphatase 1 holoenzymes containing spinophilin, neurabin and selected catalytic subunit isoforms. J Biol Chem 1999; 274:35845-35854; DOI: 10.1074/jbc.274.50.35845; PMID: 10585469.
49. Ragusa M.J., Dancheck B., Critton D.A., Nairn A.C., Page R., Peti W Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites Nat Struct Mol Biol 2010; 17:459-64; DOI: 10.1038/ nsmb.1786; PMID: 20305656.
50. Rubin E., Tamrakar S., Ludlow J.W. Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene and cell cycle control. Front Biosci 1998; 3:1209-1219; PMID: 9835651.
51. ARF during cell cycle re-entry in human T cells. Cell Cycle 2007; 6:2697-705; DOI: 10.4161/ cc.6.21.4857; PMID: 17912037.
52. Baker D.J., Jin F., van Deursen J.M. The yin and yang of the Cdkn2a locus in senescence and aging. Cell Cycle 2008; 7:2795-2802; DOI: 10.4161/cc.7.18.6687; PMID: 18769141.
53. Wells N.J., Fry A.M., Guano F., Norbury C., Hickson I.D. Cell cycle phase-specific phosphorylation of human topoisomerase II alpha. Evidence of a role for protein kinase C. J Biol Chem 1995; 270:28357-28363; PMID: 7499337.
54. Küntziger T., Landsverk H.B., Collas P., Syljuasen RG Protein phosphatase 1 regulators in DNA damage signaling Cell Cycle 2011; 10:1356-62; DOI: 10.4161/ cc.10.9.15442; PMID: 21451260.
55. Lehmann B.D., Brooks A.M., Paine M.S., Chappell W.H., McCubrey J.A., Terrian D.M. Distinct roles for p107 and p130 in Rb-independent cellular senescence. Cell Cycle 2008; 7:1262-1268; DOI: 10.4161/cc.7.9.5945; PMID: 18418057.
56. Barker H.M., Jones T.A. da Cruz e Silva EF, Spurr NK, Sheer D, Cohen PT. Localization of the gene encoding a type I protein phosphatase catalytic subunit to human chromosome band 11q13. Genomics 1990; 7:159-166; DOI: 10.1016/0888-7543(90)90536-4; PMID: 2161401.
57. Sait S.N., Dal Cin P., Sandberg A.A. Recurrent involvement of 11q13 in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1987; 26:351-354; DOI: 10.1016/0165-4608(87)90069-0; PMID: 3471314.
58. Coignet L.J., Schuuring E., Kibbelaar R.E., Raap T.K., Kleiverda K.K., Bertheas M.F., et al. Detection of 11q13 rearrangements in hematologic neoplasias by doublecolor fluorescence in situ hybridization. Blood 1996; 87:1512-1519; PMID: 8608242.
59. Carnero A., Hudson J.D., Hannon G.J., Beach D.H. Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model. Nucleic Acids Res 2000; 28:2234-2241; DOI: 10.1093/nar/28.11.2234; PMID: 10871344.
60. Ruiz L., Traskine M., Ferrer I., Castro E., Leal J.F., Kaufman M., et al. Characterization of the p53 response to oncogene-induced senescence. PLoS ONE 2008; 3:3230; DOI: 10.1371/journal.pone.0003230; PMID: 18800172.
61. waf1 in murine embryo fibroblasts. J Cell Biochem 2004; 92:514-24; DOI: 10.1002/ jcb.20079; PMID: 15156563.
62. Castro M.E., Leal J.F., Lleonart M.E., Ramon Y.C.S., Carnero A. Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function. Carcinogenesis 2008; 29:1343-1350; DOI: 10.1093/carcin/bgm302; PMID: 18515283.
63. Moneo V., Serelde B.G., Leal J.F., Blanco-Aparicio C., Diaz-Uriarte R., Aracil M., et al. Levels of p27(kip1) determine Aplidin sensitivity. Mol Cancer Ther 2007; 6:1310-1316; DOI: 10.1158/1535-7163.MCT-06-0729; PMID: 17431109.
64. Guijarro M.V., Leal J.F., Blanco-Aparicio C., Alonso S., Fominaya J., Lleonart M., et al. MAP17 enhances the malignant behavior of tumor cells through ROS increase. Carcinogenesis 2007; 28:2096-2104; DOI: 10.1093/carcin/bgm124; PMID: 17548903.
65. Link W., Oyarzabal J., Serelde B.G., Albarran M.I., Rabal O., Cebria A., et al. Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide-3-kinases. J Biol Chem 2009; 284:28392-400; DOI: 10.1074/jbc. M109.038984; PMID: 19690175.
66. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr, Butel J.S., et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-221; DOI: 10.1038/356215a0; PMID: 1552940.
67. Guijarro M.V., Link W., Rosado A., Leal J.F., Carnero A. MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation. Carcinogenesis 2007; 28:2443-2450; DOI: 10.1093/carcin/bgm154; PMID: 17675338.
68. Blanco-Aparicio C., Pequeno B., Moneo V., Romero L., Leal J.F., Velasco J., et al. Inhibition of phosphatidylinositol- 3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria. Anticancer Drugs 2005; 16:977-987; DOI: 10.1097/01.cad.0000180117.93535.cf; PMID: 16162974.